Autifony Therapeutics' Unattributed VC Round

Autifony Therapeutics raised a round of funding on March 15, 2017. Investors include Dementia Discovery Fund.

Autifony Therapeutics is an independent biotechnology company focusing on the development of high value, novel medicines to treat serious diseases of the central nervous system.…

Articles about Autifony Therapeutics' Unattributed VC Round: